• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

56
37
34
29
27

COUNTRY

16
15
11
4
2

CATEGORIES

  • 133
  • 29
  • 17
  • 7
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL…

PRICE

10
22
92
173

PUBLISHED

1
8
27
173

PRODUCT TYPE

168
2
2
1

Search "Biologics and Biosimilars World Markets" returned 173 results.

PRODUCT TITLE

Biologics and Biosimilars World Markets

Biologics are complex molecules manufactured through cell culture recombinant DNA technology Biologics additionally comprise recombinant insulin, growth hormone and monoclonal antibodies for treating...

August 2013
FROM

The Future of Biosimilars - Market Forecasts to 2015, Opportunity Analysis and Regulatory Pathways

“The Future of Biosimilars - Market Forecasts to 2015, Opportunity Analysis and Regulatory Pathways” provides insights on the biosimilars market revenues and growth until 2015 Further, the distribution...

December 2009
FROM

Biosimilars in Developed Countries - Launch of Biosimilar mAbs in Europe and New Regulatory Pathways in the US to Spur Market Growth

GBI Research, the leading business intelligence provider, has released its latest report, “Biosimilars in Developed Countries - Launch of Biosimilar mAbs in Europe and New Regulatory Pathways in the...

July 2012
FROM

Biosimilar Defensive Plays - Assessing the Options

Although biological therapeutics have developed into an increasingly valuable segment of the pharmaceutical market, the commercial impact of biosimilar products has, to date, been fairly insignificant...

June 2013
FROM
Tapping Biosimilar Opportunities Tapping Biosimilar Opportunities - Product Thumbnail Image

Tapping Biosimilar Opportunities

Tapping biosimilar opportunities A Follow on biologic (FOB) or Biosimilar, as commonly known, has been one of the most widely discussed topics in the world of pharma in the last few years The approaching...

September 2011
FROM
Biosimilars and Biobetters: Positioning for a New Market 2009 Biosimilars and Biobetters: Positioning for a New Market 2009 - Product Thumbnail Image

Biosimilars and Biobetters: Positioning for a New Market 2009

As regulatory frameworks for biosimilars development begin to take shape worldwide, there are growing opportunities for generics companies to enter the biologics market, a segment which is uniquely...

July 2009
Global Biosimilars Market - Products, Applications and Regulations Global Biosimilars Market - Products, Applications and Regulations - Product Thumbnail Image

Global Biosimilars Market - Products, Applications and Regulations

Off-Patent Biologics to Boost the Growth of Biosimilars Global Market to Reach US$19 4bn by 2018 Several of the leading 25 manufacturers of biosimilars have been entrenched in the market, and have the...

November 2012
FROM

Biosimilars Approval Pathways in the US and Europe - Development and Approval of Biosimilar mABs May Face Tough Regulatory Environment

Biosimilars Approval Pathways in the US and Europe - Development and Approval of Biosimilar mABs May Face Tough Regulatory Environment Summary GBI Research, the leading business intelligence provider,...

April 2011
FROM
Biosimilars - Global Strategic Business Report Biosimilars - Global Strategic Business Report - Product Thumbnail Image

Biosimilars - Global Strategic Business Report

This report analyzes the worldwide markets for Biosimilars in US$ Million The report provides separate comprehensive analytics for US, Europe, and Japan Annual estimates and forecasts are provided for...

April 2012
FROM
Global Biosimilars Industry Global Biosimilars Industry - Product Thumbnail Image Special Offer Sale Banner

Global Biosimilars Industry

Biosimilar is a term used to describe officially approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusivity expiry on the innovator...

October 2012
FROM
Specialty Physicians Discuss their Opinions of the United States Biosimilars Market Specialty Physicians Discuss their Opinions of the United States Biosimilars Market - Product Thumbnail Image

Specialty Physicians Discuss their Opinions of the United States Biosimilars Market

The U S biosimilars market is a fast approaching reality However, much uncertainty lies ahead, including the market potential as a function of physician adoption of biosimilars This panel discussion...

December 2011
FROM

PharmaSphere: Global Biosimilars Strategy - Regulatory Landscape, Key Drivers, Markets and Trends in 2013

PharmaSphere: Global Biosimilars Strategy - Regulatory Landscape, Key Drivers, Markets and Trends in 2013 Summary Our "PharmaSphere: Global Biosimilars Strategy - Regulatory Landscape, Key Drivers,...

May 2013
FROM
Biosimilars and Biobetters: Positioning for a New Market Biosimilars and Biobetters: Positioning for a New Market - Product Thumbnail Image

Biosimilars and Biobetters: Positioning for a New Market

As regulatory frameworks for biosimilars development begin to take shape worldwide, there are growing opportunities for generics companies to enter the biologics market, a segment which is uniquely...

July 2009
Biologic Drug R&D in China - Current State and Future Development Biologic Drug R&D in China - Current State and Future Development - Product Thumbnail Image

Biologic Drug R&D in China - Current State and Future Development

The fast growth of the Chinese bio-pharmaceutical market has been prompting the rapid development of the entire Chinese bio-pharmaceutical industry, including R&D on biological medicines. In the recent...

May 2013
FROM
Global Biosimilars Market Report: 2012 Edition Global Biosimilars Market Report: 2012 Edition - Product Thumbnail Image

Global Biosimilars Market Report: 2012 Edition

The biosimilar market is presently a small segment of the pharmaceutical industry However, in the years to come, the market for biosimilars has huge growth opportunity despite of the high entry barriers...

July 2012
FROM
Global Biosimilars: A return to optimism? Global Biosimilars: A return to optimism? - Product Thumbnail Image

Global Biosimilars: A return to optimism?

A Critical Strategic Analysis from Espicom Despite some commentators predicting a muted or near nonexistent market for advanced biosimilars, many companies – and some surprising names – are positioning...

January 2012
FROM
HGH Biosimilars Market Forecast to 2015 HGH Biosimilars Market Forecast to 2015 - Product Thumbnail Image

HGH Biosimilars Market Forecast to 2015

Across the globe, the biosimilars industry has been growing stupendously for the past few years Increasing healthcare costs and rising aging population are driving the industry that is expected to evolve...

May 2012
FROM
Biosimilars in Emerging Markets Biosimilars in Emerging Markets - Product Thumbnail Image

Biosimilars in Emerging Markets

There are few areas of the pharmaceutical market more hotly debated than biosimilars yet the pathway to developing a viable global product marketplace is not clear Biosimilar interest is being driven...

March 2013
FROM
Strategic Analysis of Indian Biosimilar Market Strategic Analysis of Indian Biosimilar Market - Product Thumbnail Image

Strategic Analysis of Indian Biosimilar Market

This research deliverable provides deep insights into the Biosimilar market in India It also includes an overview of the Indian regulatory and R&D process briefing about the biosimilars, trends in regional/local...

May 2011
FROM

Biosimilars (2009 - 2014)

The impending expiry of several patented blockbuster biopharmaceuticals and the increasing demand from patients, insurers, and government agencies to reduce drug costs have created numerous opportunities...

September 2009
FROM
Loading Indicator

Our Clients

Ikea Systems B.V. GlaxoSmithKline PLC BT Group PLC. Philips N.V. BSH Home Appliances Ltd Foreign & Commonwealth Office